Printed from Urbana-Champaign IMC : http://www.ucimc.org/
UCIMC Independent Media 
Center
Media Centers

[topics]
biotech

[regions]
united states

oceania

germany

[projects]
video
satellite tv
radio
print

[process]
volunteer
tech
process & imc docs
mailing lists
indymedia faq
fbi/legal updates
discussion

west asia
palestine
israel
beirut

united states
worcester
western mass
virginia beach
vermont
utah
urbana-champaign
tennessee
tampa bay
tallahassee-red hills
seattle
santa cruz, ca
santa barbara
san francisco bay area
san francisco
san diego
saint louis
rogue valley
rochester
richmond
portland
pittsburgh
philadelphia
omaha
oklahoma
nyc
north texas
north carolina
new orleans
new mexico
new jersey
new hampshire
minneapolis/st. paul
milwaukee
michigan
miami
maine
madison
la
kansas city
ithaca
idaho
hudson mohawk
houston
hawaii
hampton roads, va
dc
danbury, ct
columbus
colorado
cleveland
chicago
charlottesville
buffalo
boston
binghamton
big muddy
baltimore
austin
atlanta
arkansas
arizona

south asia
mumbai
india

oceania
sydney
perth
melbourne
manila
jakarta
darwin
brisbane
aotearoa
adelaide

latin america
valparaiso
uruguay
tijuana
santiago
rosario
qollasuyu
puerto rico
peru
mexico
ecuador
colombia
chile sur
chile
chiapas
brasil
bolivia
argentina

europe
west vlaanderen
valencia
united kingdom
ukraine
toulouse
thessaloniki
switzerland
sverige
scotland
russia
romania
portugal
poland
paris/ãŽle-de-france
oost-vlaanderen
norway
nice
netherlands
nantes
marseille
malta
madrid
lille
liege
la plana
italy
istanbul
ireland
hungary
grenoble
galiza
euskal herria
estrecho / madiaq
cyprus
croatia
bulgaria
bristol
belgrade
belgium
belarus
barcelona
austria
athens
armenia
antwerpen
andorra
alacant

east asia
qc
japan
burma

canada
winnipeg
windsor
victoria
vancouver
thunder bay
quebec
ottawa
ontario
montreal
maritimes
london, ontario
hamilton

africa
south africa
nigeria
canarias
ambazonia

www.indymedia.org

This site
made manifest by
dadaIMC software
&
the friendly folks of
AcornActiveMedia.com

Comment on this article | Email this Article
News :: Health
Why Interderon's Do Not Work And Boosting The Immune System Does Current rating: 0
28 Apr 2003
Scientists at two Texas universities have discovered how hepatitis C virus thwarts immune system efforts to eliminate it.
 

Why Interferon's Do Not Work
and Boosting the Immune System Does

Scientists at two Texas universities have discovered how hepatitis C virus thwarts immune system efforts to eliminate it.  The finding, published
online today in "ScienceExpress", could lead to more effective treatments for liver disease caused by hepatitis C virus, says author Michael Gale, Jr., Ph.D., of University of Texas Southwestern Medical Center at Dallas. Dr. Gale and coauthor Stanley Lemon, M.D., of University of Texas Medical Branch at Galveston, are grantees of the National Institute of Allergy and Infectious Diseases (NIAID).

"Persistent hepatitis C virus (HCV) infection is a major cause of liver
disease worldwide and is the leading reason for liver transplants in this
country," notes NIAID Director Anthony S. Fauci, M.D. "The most prevalent form of HCV in the United States is, unfortunately, the least responsive
to available treatments. Moreover, African Americans are even less responsive to therapy than Caucasians," he adds.

The immune system has many ways to detect and fight off invading microbes, and microbes have just as many ways to elude and disarm immune system components. Through a series of experiments on cells grown in the laboratory, Drs. Gale and Lemon defined the strategy HCV uses to evade the host's immune response. As HCV begins to replicate in its human host, it manufactures enzymes, called proteases, which it requires to transform viral proteins into their functional forms. The Texas investigators determined that one viral protease, NS3/4A, specifically inhibits a key immune system molecule, interferon regulatory factor-3 (IRF-3). IRF-3 orchestrates a range of antiviral responses. Without this master switch, antiviral responses never begin, and HCV can gain a foothold and persist in its host.

Next, the scientists searched for ways to reverse the IRF-3 blockade.  They applied a protease inhibitor to human cells containing modified HCV. This prevented the virus from making functional NS3/4A and restored the cells' IRF-3 pathway. Follow-up studies have shown that once restored, the immune response reduced viral levels to nearly undetectable levels within days, according to Dr. Gale.

The identification of this viral protease-regulated control of IRF-3 opens
new avenues in both clinical and basic research on hepatitis C, notes Dr.
Gale. Until now, scientists had not considered the possibility that inhibiting this protease did anything more than halt viral replication. "Now that we know NS3/4A inhibition essentially restores the host's immune response to the virus, we can assess hepatitis drug candidates for this ability as well," Dr. Gale says.

NS3/4A will be a valuable tool in further dissecting the roles of viral proteases and their host cell targets, says Dr. Gale. For example, the
scientists plan to use NS3/4A to hunt for the still unknown host cell enzyme responsible for activating IRF-3. Conceivably, Dr. Gale explains, future therapeutic approaches to viral disease could involve boosting the
activity of any key host enzymes that are found.

"Understanding the tricks that the hepatitis C virus employs to impair the
immune system represents an important advance with potential implications for successful cure of those suffering from liver disease," says Leslye
Johnson, Ph.D., chief of NIAID's enteric and hepatic diseases branch.

NIAID is a component of the National Institutes of Health (NIH), which is
an agency of the Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

National Institutes of Health

 

See also:
http://www.HepCSolutions.com
Add a quick comment
Title
Your name Your email

Comment

Text Format
To add more detailed comments, or to upload files, see the full comment form.